In this article, we explore the innovative technology of Allozymes, a Singaporean-grown start-up that is paving the way in enzyme engineering to create a more sustainable future. Read on to understand how synthetic biology and microfluidics can contribute to a greener cosmetics industry, and other future applications!
The 1st BCS Biotech Writing Competition was held in 2023 where applicants submitted their entries on current biotechnology trends and opinions in Asia. In the wake of the COVID-19 pandemic and the perpetual outbreaks of Influenza, most of us see microbes as dangerous organisms. Our 3rd prize winner, Vanessa Lunardi, writes an informative piece that proves otherwise – maybe microbes can be used to benefit humankind after all.
The 1st BCS Biotech Writing Competition was held in 2023 where applicants submitted their entries on current biotechnology trends and opinions in Asia. Our 1st runner up, Yap Wee Swan, provides a comprehensive, yet personal, perspective of cellular agriculture in Southeast Asia.
The 1st BCS Biotech Writing Competition was held in 2023 where applicants submitted their entries on current biotechnology trends and opinions in Asia. The winning entry by Jingmei Li, PhD shares about precision health screening through personal anecdotes, and its potential applications in early detection of diseases.
The second article of the career series interviews Dr. Wen Qi Ho, previous Vice-President of Lightstone Ventures and current Director of Investments and New Ventures at ClavystBio. Read on to learn more about the transition from academia to VC.
Wonder what it’s like to be a founder of a deep-tech company in Singapore? Biotech Connection Singapore is kickstarting our Career Series Interviews again! In this interview, we speak with Dr. Peyman Salehian, co-founder and CEO of Singapore-based startup Allozymes. What does it take to make a deep-tech company like Allozymes work? What are the challenges one must be prepared to face? And what takeaways can we glean from Dr. Peyman’s experiences? Read on to find out more.
Senescence and aging are two terms that many are not familiar with, and they come with their fair share of associated maladies. But with the recent discovery of senolytics, is it possible to halt aging in its tracks? In this joint collaboration with A*STAR, we discuss the current progress and potential of senolytics.
In this interview, we spoke to Dr Percy Luu, Founder and CEO of Incando Therapeutics to find out about his experience starting and growing a very early-stage therapeutics start-up company in Singapore.
COVID-19 has greatly affected the construction industry by causing employee absenteeism, a problem which leads to project delays and loss of revenue for many companies. Hear about how Genscript’s new SARS-CoV-2 cPass™ serology test for neutralising antibodies has been helping construction workers make informed decisions to take vaccine boosters and stay protected.